A 64-year-old woman presented to an outside provider with 5 days of left eye “burning, itching, redness and blurry vision” and 1 day of acute “9 out of 10” left eye pain.She had a medical history of ...

The U.S. is the world’s largest producer of oil and natural gas. There are almost 1 million producing wells across the ...

Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with ...

Scientists at Indiana University School of Medicine have identified a new approach that could transform treatment for acute ...

MUSC researchers at the Hollings Cancer center are making strides in new developments for leukemia treatment.Sophie Paczesny, ...

Panelists advocate for a streamlined approach to diagnosing KMT2A-rearranged acute myeloid leukemia (AML) that includes standardized testing protocols (cytogenetics, fluorescence in situ hybridization ...

The patients receiving AHSCT had 5-year LFS of 46.3% and OS of 53.3%, which were better outcomes than those of the MRC UKALL XII/ECOG E2993 trial conducted from 2006 to 2010.

A panelist discusses how ASCO 2025's most important breakthrough was the oral decitabine plus venetoclax combination, representing a potential paradigm shift if approved by the FDA, while highlighting ...

A large new study has confirmed the clinical relevance of a pharmacogenomic score that could help tailor leukaemia treatment ...